This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a specialty pharmaceutical product, REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML. The total ceiling value of this delivery order is $163,843.99. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. The contract has a ceiling value of $7,763.13 and a period of performance through May 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,629.12 firm fixed-price delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,070.04 firm fixed-price award is for the supply of Rebif 44 mcg/0.5 ml syringes, a specialty medication, with a performance period through April 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $12,150.01, is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of the pharmaceutical product Rebif 44 mcg/0.5 mL syringe. The $4,131.04 firm fixed price delivery order has an ultimate completion date of August 19, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $8,202.62 and is a firm fixed price delivery order that runs through August 2024. No set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides pharmaceutical and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $18,374.02 firm-fixed-price delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, with a completion date of August 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with a firm fixed price ceiling value of $27,934.71 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the U.S. government. The contract, valued at $17,588.13, was awarded by the Medical Supply Chain, which is part of the Defense agency. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this Firm Fixed Price delivery order contract with a completion date of May 16, 2024. The company holds a...